2024-11-12  9:43:11 PM Chg. -0.405 Volume Bid9:45:45 PM Ask9:45:45 PM Market Capitalization Dividend Y. P/E Ratio
16.690EUR -2.37% 7,274
Turnover: 121,202.375
16.675Bid Size: 270 16.740Ask Size: 270 66.19 bill.EUR - -

Business description

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.
 

Management board & Supervisory board

CEO
Emma Walmsley
Management board
Julie Brown, Diana Conrad, James Ford, Luke Miels, Sally Jackson, Tony Wood, Shobie Ramakrishnan, David Redfern, Regis Simard, Phil Thomson, Deborah Waterhouse
Supervisory board
Jonathan Symonds, Emma Walmsley, Iain Mackay, Elizabeth (Liz) McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Harry (Hal) C Dietz, Dr. Jesse Goodman, Urs Rohner, Dr. Vishal Sikka, Wendy Becker, Dr. Jeannie Lee
 

Company data

Name: GlaxoSmithKline PLC
Address: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Phone: +44-20-8047-5000
Fax: -
E-mail: -
Internet: www.gsk.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: 41.74%
IPO date: -

Investor relations

Name: Nick Stone
IR phone: +44 7717 618834
IR Fax: -
IR e-mail: GSK.Investor-Relations@gsk.com

Company calendar

CW 46 | 2024-11-14 Ex-Dividend
CW 46 | 2024-11-15 Record Date
CW 2 | 2025-01-09 Dividend Payment
CW 6 | 2025-02-05 Report 4th Quarter
CW 8 | 2025-02-20 Ex-Dividend
 

Main Shareholders

Others
 
89.27%
BlackRock, Inc
 
5.69%
Dodge & Cox
 
5.04%